Published in Antimicrob Agents Chemother on June 01, 1988
A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother (1995) 26.51
beta-Lactamases in laboratory and clinical resistance. Clin Microbiol Rev (1995) 12.53
Carbapenem-hydrolyzing beta-lactamases. Antimicrob Agents Chemother (1997) 7.17
Classification of beta-lactamases: groups 2c, 2d, 2e, 3, and 4. Antimicrob Agents Chemother (1989) 4.10
The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol (2008) 2.71
Nucleotide sequence analysis of a gene from Burkholderia (Pseudomonas) cepacia encoding an outer membrane lipoprotein involved in multiple antibiotic resistance. Antimicrob Agents Chemother (1996) 1.76
Salicylate-inducible antibiotic resistance in Pseudomonas cepacia associated with absence of a pore-forming outer membrane protein. Antimicrob Agents Chemother (1992) 1.50
Characterization of the penA and penR genes of Burkholderia cepacia 249 which encode the chromosomal class A penicillinase and its LysR-type transcriptional regulator. Antimicrob Agents Chemother (1997) 1.41
Salicylate induces an antibiotic efflux pump in Burkholderia cepacia complex genomovar III (B. cenocepacia). J Clin Invest (2004) 1.18
The Pseudomonas cepacia 249 chromosomal penicillinase is a member of the AmpC family of chromosomal beta-lactamases. Antimicrob Agents Chemother (1993) 1.04
Naturally occurring Class A ss-lactamases from the Burkholderia cepacia complex. Antimicrob Agents Chemother (2008) 0.94
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis. Antimicrob Agents Chemother (1999) 0.90
Analysis of the penA gene of Pseudomonas cepacia 249. Antimicrob Agents Chemother (1994) 0.80
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res (1979) 214.95
Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol (1978) 75.38
Novel method for detection of beta-lactamases by using a chromogenic cephalosporin substrate. Antimicrob Agents Chemother (1972) 61.10
Simple method for identification of plasmid-coded proteins. J Bacteriol (1979) 20.53
Construction of a broad host range cosmid cloning vector and its use in the genetic analysis of Rhizobium mutants. Gene (1982) 20.39
The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics. J Antimicrob Chemother (1976) 18.58
Micro-iodometric assay for penicillinase. Biochem J (1962) 16.45
An efficient and reproducible procedure for the formation of spheroplasts from variously grown Escherichia coli. Anal Biochem (1976) 5.79
Utilization of two distinct modes of replication by a hybrid plasmid constructed in vitro from separate replicons. Proc Natl Acad Sci U S A (1974) 4.27
Purification and properties of a new beta-lactamase from Pseudomonas cepacia. Antimicrob Agents Chemother (1980) 4.09
Purification and properties of an inducible cephalosporinase from Pseudomonas maltophilia GN12873. Antimicrob Agents Chemother (1984) 3.07
Methodology for the study of beta-lactamases. Antimicrob Agents Chemother (1986) 2.82
Broad host range plasmid RK2 encodes multiple kil genes potentially lethal to Escherichia coli host cells. Proc Natl Acad Sci U S A (1982) 2.66
Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J Pediatr (1986) 2.38
Sequence elements determining ampC promoter strength in E. coli. EMBO J (1982) 2.35
Common evolutionary origin of chromosomal beta-lactamase genes in enterobacteria. J Bacteriol (1982) 2.24
Common mechanism of ampC beta-lactamase induction in enterobacteria: regulation of the cloned Enterobacter cloacae P99 beta-lactamase gene. J Bacteriol (1987) 2.13
Induction kinetics of beta-lactamase biosynthesis in Pseudomonas aeruginosa. Antimicrob Agents Chemother (1974) 1.85
Ceftazidime alone and in combination in patients with cystic fibrosis: lack of efficacy in treatment of severe respiratory infections caused by Pseudomonas cepacia. J Antimicrob Chemother (1983) 1.60
Response of Pseudomonas cepacia to beta-Lactam antibiotics: utilization of penicillin G as the carbon source. J Bacteriol (1979) 1.58
Role of porins in intrinsic antibiotic resistance of Pseudomonas cepacia. Antimicrob Agents Chemother (1987) 1.29
Decreased baseline beta-lactamase production and inducibility associated with increased piperacillin susceptibility of Pseudomonas cepacia isolated from children with cystic fibrosis. Pediatr Res (1986) 1.00
Isolation of a DNA fragment containing replication functions from IncP2 megaplasmid pMG2. J Bacteriol (1985) 0.96
Purification and properties of inducible penicillin beta-lactamase isolated from Alcaligenes faecalis. Antimicrob Agents Chemother (1985) 0.93
Nucleotide sequence, secondary structure and evolution of the 5S ribosomal RNA from five bacterial species. Eur J Biochem (1985) 0.79
Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1984) 8.62
Multicenter evaluation of proposed standardized procedure for antifungal susceptibility testing of filamentous fungi. J Clin Microbiol (1997) 5.64
In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new beta-lactams, aminoglycosides, and trimethoprim. Antimicrob Agents Chemother (1983) 5.21
In vitro activity of Ro 23-6240, a new fluorinated 4-quinolone. Antimicrob Agents Chemother (1986) 3.98
Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin. Antimicrob Agents Chemother (1984) 3.40
Departmental libraries: why do they exist? Bull Med Libr Assoc (1977) 2.73
Comparative in vitro activity of a new fluorinated 4-quinolone, T-3262 (A-60969). Antimicrob Agents Chemother (1988) 2.52
Post-antibiotic suppressive effect of ciprofloxacin against gram-positive and gram-negative bacteria. Am J Med (1987) 2.13
In vitro activity of S-ofloxacin. Antimicrob Agents Chemother (1989) 2.10
In vitro activity of the new fluoroquinolone CP-99,219. Antimicrob Agents Chemother (1994) 2.03
In vitro activity and beta-lactamase stability of a new carbapenem, SM-7338. Antimicrob Agents Chemother (1989) 1.94
Development of SDI services from a manual current awareness service to SDILINE. Bull Med Libr Assoc (1974) 1.85
Comparative in vitro activity of a new quinolone, AM-1091. Antimicrob Agents Chemother (1989) 1.78
In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105. Antimicrob Agents Chemother (1988) 1.75
In vitro activity against aerobic and anaerobic gram-positive and gram-negative bacteria and beta-lactamase stability of RS-533, a novel carbapenem. Antimicrob Agents Chemother (1986) 1.74
Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin. Antimicrob Agents Chemother (1989) 1.67
In vitro activity and beta-lactamase stability of two oral cephalosporins, ceftetrame (Ro 19-5247) and cefetamet (Ro 15-8074). Antimicrob Agents Chemother (1986) 1.60
Comparative antibacterial activity of a new oral cephalosporin, BMY-28100. Antimicrob Agents Chemother (1987) 1.54
In vitro activity and beta-lactamase stability of a new penem, CGP 31608. Antimicrob Agents Chemother (1987) 1.53
In vitro activity of E-1040, a novel cephalosporin with potent activity against Pseudomonas aeruginosa. Antimicrob Agents Chemother (1988) 1.53
Criteria-based evaluation of group 3 level memory telefacsimile equipment for interlibrary loan. Bull Med Libr Assoc (1990) 1.51
A medical library's response to Three Mile Island. Bull Med Libr Assoc (1980) 1.40
The in-vitro activity of a novel penem FCE 22101 compared to other beta-lactam antibiotics. J Antimicrob Chemother (1985) 1.37
The activity and beta-lactamase stability of cefotetan compared to other beta-lactam antibiotics. Chemioterapia (1985) 1.33
The in-vitro activity of new streptogramins, RP 59500, RP 57669 and RP 54476, alone and in combination. J Antimicrob Chemother (1992) 1.26
In vitro activity of OPC-17116. Antimicrob Agents Chemother (1992) 1.26
Antibacterial activity of coumermycin alone and in combination with other antibiotics. Antimicrob Agents Chemother (1984) 1.24
Pharmacology of ticarcillin combined with clavulanic acid in humans. Am J Med (1985) 1.23
In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin. Antimicrob Agents Chemother (1993) 1.23
Activity of A-56268 compared with that of erythromycin and other oral agents against aerobic and anaerobic bacteria. Antimicrob Agents Chemother (1987) 1.18
The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin. J Antimicrob Chemother (1986) 1.15
Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection. Eur J Clin Microbiol (1986) 1.12
In vitro activity of ME1228, a new parenteral cephalosporin. Antimicrob Agents Chemother (1989) 1.07
Resistance of Xanthomonas maltophilia to antibiotics and the effect of beta-lactamase inhibitors. Diagn Microbiol Infect Dis (1989) 0.99
The in-vitro activity and beta-lactamase stability of carumonam. J Antimicrob Chemother (1986) 0.98
Comparative in vitro activity of the new oral macrolide azithromycin. Eur J Clin Microbiol Infect Dis (1988) 0.95
In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae. Antimicrob Agents Chemother (1994) 0.93
Synergy of imipenem--a novel carbapenem, and rifampin and ciprofloxacin against Pseudomonas aeruginosa, Serratia marcescens and Enterobacter species. Chemotherapy (1987) 0.93
Cefotaxime and desacetylcefotaxime: an example of advantageous antimicrobial metabolism. Diagn Microbiol Infect Dis (1984) 0.92
The post-antimicrobial suppressive effect of quinolone agents. Drugs Exp Clin Res (1987) 0.92
A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance. Chemioterapia (1985) 0.92
Effect of ciprofloxacin on fecal flora of patients with cystic fibrosis and other patients treated with oral ciprofloxacin. Am J Med (1987) 0.91
In vitro activity of pefloxacin compared to that of quinolones and other antimicrobial agents. Chemioterapia (1984) 0.90
In vitro activity of PD 117596-2, a broad-spectrum difluoroquinolone. Eur J Clin Microbiol Infect Dis (1989) 0.89
Synergy of fosfomycin with beta-lactam antibiotics against staphylococci and aerobic gram-negative bacilli. Drugs Exp Clin Res (1986) 0.87
The in vitro activity and beta-lactamase stability of cefpirome (HR 810), a pyridine cephalosporin agent active against staphylococci, Enterobacteriaceae and Pseudomonas aeruginosa. Infection (1985) 0.86
In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343. J Antimicrob Chemother (1985) 0.86
In-vitro activity of two new quinolone antimicrobial agents, S-25930 and S-25932 compared with that of other agents. J Antimicrob Chemother (1987) 0.85
Synergy of azlocillin with aminoglycosides. J Antimicrob Chemother (1983) 0.84
In vitro activity and beta-lactamase stability of a new monobactam, B0-1165. Antimicrob Agents Chemother (1987) 0.84
In vitro activity and beta-lactamase stability of LJC 10,627. Antimicrob Agents Chemother (1992) 0.83
In-vitro activity and beta-lactamase stability of LY163892. J Antimicrob Chemother (1988) 0.82
In vitro activity of the new glycopeptide decaplanin. Eur J Clin Microbiol Infect Dis (1992) 0.82
In vitro activity and beta-lactamase stability of a new difluoro oxacephem, 6315-S. Antimicrob Agents Chemother (1986) 0.82
The in vitro activity and beta-lactamase stability of cefpiramide compared with other beta-lactam antibiotics. Diagn Microbiol Infect Dis (1985) 0.81
Distribution of opioid binding sites in spinal cord. Neuropeptides (1988) 0.81
The pharmacology of clavulanic acid and ticarcillin combined. Chemioterapia (1984) 0.80
Age-related deficits in retention of the classically conditioned nictitating membrane response in rabbits. Behav Neurosci (1995) 0.79
A survey of dermatophytes isolated from human patients in the United States from 1993 to 1995. J Am Acad Dermatol (1998) 0.79
Nimodipine facilitates retention of the classically conditioned nictitating membrane response in aged rabbits over long retention intervals. Neurobiol Aging (1996) 0.79
In vitro activity of fleroxacin in combination with other antimicrobial agents. Am J Med (1993) 0.78
Medical Journals of Pennsylvania before the Civil War. Trans Stud Coll Physicians Phila (1983) 0.78
Structural-functional correlates of neuroprotection in the aging rabbit by a calcium channel blocker. Nimodipine reverses neocortical dendritic atrophy and improves memory retention. Ann N Y Acad Sci (1995) 0.77
Comparative antibacterial activity of an arylglycyl oral cephalosporin, LY164846. Antimicrob Agents Chemother (1986) 0.77
Synergy of sulbactam and ampicillin against methicillin-resistant staphylococci. Drugs Exp Clin Res (1986) 0.77
Modified melanocortin tetrapeptide Ac-His-dPhe-Arg-Trp-NH at the arginine side chain with ureas and thioureas. J Pept Res (2005) 0.76
Effect of fees on an information service for physicians. Bull Med Libr Assoc (1978) 0.75
In vitro activity and susceptibility to hydrolysis of S-1006. Antimicrob Agents Chemother (1992) 0.75
In vitro activity of an oxycephem OCP 9-176 compared with its sulfur analog and other beta-lactams. Diagn Microbiol Infect Dis (1991) 0.75
Comparative in vitro activity and beta-lactamase stability of CGP 31523A, a new aminothiazolyl cephalosporin. Chemioterapia (1986) 0.75
Penicillin-nonsusceptible pneumococcus in acute otitis media in New York City. Otolaryngol Head Neck Surg (1999) 0.75
Antimicrobial activity and beta-lactamase stability of SK&F 88070 compared with other agents. Diagn Microbiol Infect Dis (1986) 0.75
Kappa opioid binding sites in rat spinal cord. NIDA Res Monogr (1986) 0.75
Antibacterial activity of rokitamycin compared with that of other macrolides. Diagn Microbiol Infect Dis (1991) 0.75
Nonsusceptible Streptococcus pneumoniae in children with chronic otitis media with effusion and recurrent otitis media undergoing ventilating tube placement. Pediatr Infect Dis J (2000) 0.75
In vitro activity of CP-74,667. A new fluoroquinolone compared with other quinolones. Diagn Microbiol Infect Dis (1992) 0.75
Aza-scanning of the potent melanocortin receptor agonist Ac-His-D-Phe-Arg-Trp-NH. Chem Biol Drug Des (2006) 0.75
Tazobactam prevention of emergence of resistance. Diagn Microbiol Infect Dis (1990) 0.75
Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B. Eur J Clin Microbiol Infect Dis (1992) 0.75
The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin. Chemioterapia (1985) 0.75